KZIA logo

KZIA

Profile

Full Name

Kazia Therapeutics Limited

Ticker Symbol

KZIA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

January 6, 1999

Indexes

Not included

Website

http://www.kaziatherapeutics.com

Employees

9

Key Details

Price

$3.54(-2.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.51M

Annual EPS

-$6.66(+12.00% YoY)

PE ratio

-

Next earnings date

Apr 18, 2025

Next ex-dividend date

N/A

Next split date

Apr 17, 2025

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.54
KZIA price is $3.54

30-Day Relative Volume

0.06
KZIA 30-day relative volume is 0.06

Price Performance

Price Most recent change

-2.37%
KZIA price was down -2.37% on Apr 16, 2025

Price YTD change

+99.97%
KZIA price is up +99.97% since January 1st

Price 1-year change

+2.83%
KZIA price is up +2.83% year-on-year

Price 3-year change

-95.36%
KZIA price is down -95.36% over the past 3 years

Price Range

Price All-time high

$2100.07
KZIA price is currently -99.83% below its historical high of $2100.07

Price 3-year low

$0.76
KZIA price is currently +365.72% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$19.78M
KZIA market capitalization is $19.78 million

Market cap 3-year change

-80.63%
KZIA market capitalization is down -80.63% over the past 3 years

Market cap All-time high

$196.61M
KZIA market capitalization is currently -89.94% below its historical high of $196.61 million

Market cap sector rank

27.06%
KZIA market capitalization is higher than 27.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+112.02%
KZIA shares outstanding is up +112.02% year-on-year

Shares Outstanding 3-Year Change

+317.45%
KZIA shares outstanding is up +317.45% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-3.57
KZIA beta is -3.57

200-day SMA

$3.30
KZIA price is currently +7.20% above its 200-day simple moving average

50-day SMA

$1.49
KZIA price is currently +137.17% above its 50-day simple moving average

RSI

71.10
KZIA 14-day relative strength index is 71.10

Volume

0.06
KZIA 30-day relative volume is 0.06

ATR

$0.40
KZIA average true range is $0.40

10-day Historical Volatility

1968.22%
KZIA 10-day historical volatility is 1968.22%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.51M
KZIA annual revenue is $1.51 million

Revenue Analysts estimate

-
KZIA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
KZIA annual revenue 1-year change is unknown

Revenue Sector rank

13.77%
KZIA annual revenue is higher than 13.77% of companies in Healthcare sector

EPS

EPS

-$6.66
KZIA annual earnings per share is -$6.66

EPS Analysts estimate

-$0.05
KZIA annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

EPS 1-year change

+12%
KZIA annual earnings per share is up +12% year-on-year

EPS Sector rank

15.37%
KZIA annual earnings per share is higher than 15.37% of companies in Healthcare sector

Profit

Gross profit

-
KZIA annual gross profit value is unknown

Gross margin

-
KZIA annual gross profit margin value is unknown

Operating profit

-$18.77M
KZIA annual operating income is -$18.77 million

Operating margin

-1240.69%
KZIA annual operating profit margin is -1240.69%

Net income

-$17.55M
KZIA annual net profit is -$17.55 million

Net margin

-1160.23%
KZIA annual net profit margin is -1160.23%

Expenses

Total expenses

$20.29M
KZIA annual total expenses is $20.29 million

Operating expenses

$20.29M
KZIA annual total operating expenses is $20.29 million

Cost of goods sold

-
KZIA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.89M
KZIA annual SGA is $8.89 million

Depreciation and amortization

$1.23M
KZIA annual depreciation & amortization is $1.23 million

Interest expense

-
KZIA annual interest expense value is unknown

Income tax

-$177.70K
KZIA annual income tax is -$177.70 thousand

EBIT & EBITDA

EBIT

-$18.77M
KZIA annual earnings before interest & taxes is -$18.77 million

EBITDA

-$17.55M
KZIA annual EBITDA is -$17.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$14.43M
KZIA annual total assets is $14.43 million

Non current assets

$10.32M
KZIA annual long term assets is $10.32 million

Current assets

$4.11M
KZIA annual total current assets is $4.11 million

Cash and cash equivalents

$1.11M
KZIA annual cash & cash equivalents is $1.11 million

Accounts receivable

$0.00
KZIA annual accounts receivable is $0.00

Inventory

-
KZIA annual inventory value is unknown

Liabilities

Total liabilities

$21.12M
KZIA annual total liabilities is $21.12 million

Long term liabilities

$3.88M
KZIA annual total long term liabilities is $3.88 million

Current liabilities

$17.24M
KZIA annual total current liabilities is $17.24 million

Accounts payable

$3.04M
KZIA annual accounts payable is $3.04 million

Debt

Total debt

$423.80K
KZIA annual total debt is $423.80 thousand

Total debt 1-year change

-64.35%
KZIA annual total debt is down -64.35% year-on-year

Long term debt

-
KZIA annual long term debt value is unknown

Short term debt

$423.80K
KZIA annual short term debt is $423.80 thousand

Equity & Capital

Shareholders equity

-$6.70M
KZIA annual stockholders equity is -$6.70 million

Book value

-$6.70M
KZIA annual book value is -$6.70 million

Retained earnings

-$76.95M
KZIA annual retained earnings is -$76.95 million

Working capital

-$13.14M
KZIA annual working capital is -$13.14 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.28M
KZIA annual cash flow from operations is -$6.28 million

Cash from operations 1-year change

+38.4%
KZIA annual cash flow from operations is up +38.4% year-on-year

Cash from investing

$0.00
KZIA annual cash flow from investing activities is $0.00

Cash from investing 1-year change

0%
KZIA {parameterFullLabel} has remained unchanged year-on-year

Cash from financing

$3.92M
KZIA annual cash flow from financing activities is $3.92 million

Cash from financing 1-year change

-55.04%
KZIA annual cash flow from financing activities is down -55.04% year-on-year

CAPEX

CAPEX

-
KZIA annual capital expenditures value is unknown

CAPEX 1-year change

-
KZIA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$6.28M
KZIA annual free cash flow is -$6.28 million

Free cash flow 1-year change

+38.4%
KZIA annual free cash flow is up +38.4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
KZIA annual gross profit margin value is unknown

Operating margin

-1240.69%
KZIA annual operating profit margin is -1240.69%

Net margin

-1160.23%
KZIA annual net profit margin is -1160.23%

ROA & ROE

ROA

-106.34%
KZIA annual return on assets is -106.34%

ROE

-2741.04%
KZIA annual return on equity is -2741.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KZIA price to earnings ratio value is unknown

PE ratio Sector rank

-
KZIA price to earnings ratio is unknown

PB Ratio

PB ratio

-2.95
KZIA price to book ratio is -2.95

PB ratio Sector rank

5.6%
KZIA price to book ratio is higher than 5.6% of companies in Healthcare sector

PS Ratio

PS ratio

-
KZIA price to sales ratio value is unknown

PS ratio Sector rank

-
KZIA price to sales ratio is unknown

Enterprise value

Enterprise value

$19.10M
KZIA enterprise value is $19.10 million

Enterprise value Sector rank

31.3%
KZIA enterprise value is higher than 31.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
KZIA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
KZIA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.24
KZIA annual current ratio is 0.24

Quick ratio

-
KZIA annual quick ratio value is unknown

Leverage

Debt to equity

-0.06
KZIA annual debt to equity ratio is -0.06

Interest coverage ratio

-
KZIA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
KZIA piotroski f-score value is unknown

Altman Z-Score

-12.19
KZIA altman z-score is -12.19

Analyst ratings

Recent major analysts updates

Feb 6, 25 Maxim Group
Buy
Jul 12, 24 HC Wainwright & Co.
Buy
Apr 11, 23 HC Wainwright & Co.
Buy
Aug 2, 22 Maxim Group
Hold
Aug 2, 22 HC Wainwright & Co.
Neutral
Oct 14, 21 Maxim Group
Buy
Jan 5, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ENZ logo
Enzo Biochem (ENZ)
PMN logo
ProMIS Neurosciences (PMN)
ELEV logo
Elevation Oncology (ELEV)
IPA logo
ImmunoPrecise Antibodies (IPA)
NEPH logo
Nephros (NEPH)
CDIO logo
Cardio Diagnostics Holdings (CDIO)
CVM logo
CEL-SCI (CVM)
PULM logo
Pulmatrix (PULM)
OVID logo
Ovid Therapeutics (OVID)
  • What is the ticker symbol for Kazia Therapeutics Limited?
  • Does Kazia Therapeutics Limited pay dividends?
  • What sector is Kazia Therapeutics Limited in?
  • What industry is Kazia Therapeutics Limited in?
  • What country is Kazia Therapeutics Limited based in?
  • When did Kazia Therapeutics Limited go public?
  • Is Kazia Therapeutics Limited in the S&P 500?
  • Is Kazia Therapeutics Limited in the NASDAQ 100?
  • Is Kazia Therapeutics Limited in the Dow Jones?
  • When was Kazia Therapeutics Limited's last earnings report?
  • When does Kazia Therapeutics Limited report earnings?

What is the ticker symbol for Kazia Therapeutics Limited?

The ticker symbol for Kazia Therapeutics Limited is NASDAQ:KZIA

Does Kazia Therapeutics Limited pay dividends?

No, Kazia Therapeutics Limited does not pay dividends

What sector is Kazia Therapeutics Limited in?

Kazia Therapeutics Limited is in the Healthcare sector

What industry is Kazia Therapeutics Limited in?

Kazia Therapeutics Limited is in the Biotechnology industry

What country is Kazia Therapeutics Limited based in?

Kazia Therapeutics Limited is headquartered in Australia

When did Kazia Therapeutics Limited go public?

Kazia Therapeutics Limited's initial public offering (IPO) was on January 6, 1999

Is Kazia Therapeutics Limited in the S&P 500?

No, Kazia Therapeutics Limited is not included in the S&P 500 index

Is Kazia Therapeutics Limited in the NASDAQ 100?

No, Kazia Therapeutics Limited is not included in the NASDAQ 100 index

Is Kazia Therapeutics Limited in the Dow Jones?

No, Kazia Therapeutics Limited is not included in the Dow Jones index

When was Kazia Therapeutics Limited's last earnings report?

Kazia Therapeutics Limited's most recent earnings report was on Mar 27, 2024

When does Kazia Therapeutics Limited report earnings?

The next expected earnings date for Kazia Therapeutics Limited is Apr 18, 2025
On this page